SEC Form 4 · accession 0000899243-18-019664
Amneal Pharmaceuticals, Inc. · AMRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sheldon Hirt
Officer — SVP, GC & Corp. Sec.
Period of report
Jul 5, 2018
Accepted (ET)
Jul 9, 2018 · 5:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001723128
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jul 5, 2018 | J | 34,993 | $0.00 | A | 34,993 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a pro rata in-kind distribution of Class A Common Stock by APHC Holdings, LLC to its members who are holders of profit participation units.